AIHC Capital Management Ltd — 13F Holdings & Portfolio
CIK 2103725 · latest 13F-HR filed 2026-08-13
AIHC Capital Management Ltd manages $104.2M in 13F-reported U.S. long-equity assets across 4 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RVMD (54.46%), ORIC (39.77%), NBP (5.38%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 1, added to 2, and trimmed 1.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
41 CONNAUGHT ROAD CENTRAL
CENTRAL 00000
$104.2M
Long-equity book
4
Distinct positions
2026-06-30
Filed 2026-08-13
+0 / −1 / ↑2 / ↓1
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ORIC PHARMACEUTICALS INC$10.3M +33.1%
- KORRO BIO INC$56.3K +16.4%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $56.8M | 54.46% | 303,133 | SH |
| 2 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $41.5M | 39.77% | 3,828,460 | SH |
| 3 | NOVABRIDGE BIOSCIENCES | NBP | 44975P103 | $5.6M | 5.38% | 2,878,033 | SH |
| 4 | KORRO BIO INC | KRRO | 500946108 | $398.9K | 0.38% | 30,265 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-13 | $104.2M | 4 | 0001172661-26-003381 |
| 2026-03-31 | 2026-05-08 | $119.7M | 5 | 0001172661-26-001629 |
| 2025-12-31 | 2026-02-05 | $106.7M | 6 | 0001172661-26-000478 |